| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Evgeniy Krastev, Dimitar Tcharaktchiev, Emanuil Marko. System of Criteria for Treatment Evaluation of Acromegaly in Bulgaria. Studies in health technology and informatics. vol 272. 2020-08-28. PMID:32604690. |
acromegaly is a rare endocrine disorder caused by excessive and longstanding secretion of growth hormone (gh) by the pituitary somatotroph and resulting from this overproduction of insulin-like growth factor-1 hormone (igf-1) by the liver. |
2020-08-28 |
2023-08-13 |
human |
| Evgeniy Krastev, Dimitar Tcharaktchiev, Emanuil Marko. System of Criteria for Treatment Evaluation of Acromegaly in Bulgaria. Studies in health technology and informatics. vol 272. 2020-08-28. PMID:32604690. |
the here reported results provide evidence about the difficulties in maintaining both gh and igf-1 levels inside their reference values in acromegaly treatment. |
2020-08-28 |
2023-08-13 |
human |
| Tao Xie, Pei Tian, Silin Wu, Xiaobiao Zhang, Tengfei Liu, Ye Gu, Chongjing Sun, Fan H. Serum phosphate: Does it more closely reflect the true state of acromegaly? Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia. vol 71. 2020-08-05. PMID:31859176. |
an increased serum phosphate (p) level is common in acromegaly patients, however, the relationships among p, growth hormone (gh), insulin-like growth factor 1 (igf-1) and disease status remain unknown. |
2020-08-05 |
2023-08-13 |
Not clear |
| Tao Xie, Pei Tian, Silin Wu, Xiaobiao Zhang, Tengfei Liu, Ye Gu, Chongjing Sun, Fan H. Serum phosphate: Does it more closely reflect the true state of acromegaly? Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia. vol 71. 2020-08-05. PMID:31859176. |
we measured the serum p, calcium, gh, oral glucose tolerance test-gh (ogtt-gh), igf-1, and insulin-like growth factor binding protein-3 (igbp-3) levels in 103 acromegaly patients. |
2020-08-05 |
2023-08-13 |
Not clear |
| Mai C Arlien-Søborg, Camilla Grøndahl, Amanda Bæk, Jakob Dal, Michael Madsen, Morten Lyng Høgild, Steen B Pedersen, Mette Bjerre, Jens O L Jørgense. Fibroblast Activation Protein is a GH Target: A Prospective Study of Patients with Acromegaly Before and After Treatment. The Journal of clinical endocrinology and metabolism. vol 105. issue 1. 2020-07-27. PMID:31544947. |
fibroblast activation protein is a gh target: a prospective study of patients with acromegaly before and after treatment. |
2020-07-27 |
2023-08-13 |
Not clear |
| Eva Venegas-Moreno, Alvaro Flores-Martinez, Elena Dios, Mari C Vazquez-Borrego, Alejandro Ibañez-Costa, Ainara Madrazo-Atutxa, Miguel A Japón, Justo P Castaño, Raúl M Luque, David A Cano, Alfonso Soto-Moren. E-cadherin expression is associated with somatostatin analogue response in acromegaly. Journal of cellular and molecular medicine. vol 23. issue 5. 2020-07-24. PMID:30843342. |
acromegaly is a rare disease resulting from hypersecretion of growth hormone (gh) and insulin-like growth factor 1 (igf1) typically caused by pituitary adenomas, which is associated with increased mortality and morbidity. |
2020-07-24 |
2023-08-13 |
Not clear |
| Emil Natchev, Silvia Vandeva, Roussanka Kovatcheva, Georgi Kirilov, Krasimir Kalinov, Sabina Zachariev. Thyroid gland changes in patients with acromegaly. Archives of endocrinology and metabolism. vol 64. issue 3. 2020-06-29. PMID:32555993. |
acromegaly is characterized by high neoplastic morbidity as a side effect of growth hormone (gh) hypersecretion. |
2020-06-29 |
2023-08-13 |
Not clear |
| Rajkishor Nishad, Dhanunjay Mukhi, Syed V Tahaseen, Sathish Kumar Mungamuri, Anil K Pasupulat. Growth hormone induces Notch1 signaling in podocytes and contributes to proteinuria in diabetic nephropathy. The Journal of biological chemistry. vol 294. issue 44. 2020-06-12. PMID:31511328. |
growth hormone (gh) plays a significant role in normal renal function and overactive gh signaling has been implicated in proteinuria in diabetes and acromegaly. |
2020-06-12 |
2023-08-13 |
human |
| Mehmet Calan, Mustafa Demirpenc. Increased circulating levels of irisin are associated with cardiovascular risk factors in subjects with acromegaly. Hormones (Athens, Greece). vol 18. issue 4. 2020-05-29. PMID:31696447. |
acromegaly is a rare disorder caused by overproduction of growth hormone (gh) and is associated with functional and structural differentiation of adipose and muscle tissues. |
2020-05-29 |
2023-08-13 |
human |
| Shozo Yamada, Lucia Stefaneanu, Eva Horvath, Kalman Kovacs, Kesava Redd. Morphologically unclassified GH-producing adenoma showing galactorrhea without acromegaly. Endocrine pathology. vol 4. issue 1. 2020-05-06. PMID:32370439. |
a 24-year-old woman with a large pituitary adenoma had amenorrhea and galactorrhea, but no physical stigmata of acromegaly despite slightly elevated serum growth hormone (gh) and normal serum prolactin (prl) levels. |
2020-05-06 |
2023-08-13 |
Not clear |
| Aart J van der Lely, Emmanuelle Kuhn, Ammar Muhammad, Eva C Coopmans, Sebastian J Neggers, Philippe Chanso. Pegvisomant and not somatostatin receptor ligands (SRLs) is first-line medical therapy for acromegaly. European journal of endocrinology. vol 182. issue 6. 2020-05-04. PMID:32234975. |
in this issue of the journal, a pro- and contra debate will outline which arguments are in favour and which are against positioning pegvisomant (pegv), a gh receptor antagonist, as the first-line treatment modality of acromegaly. |
2020-05-04 |
2023-08-13 |
Not clear |
| M Kužma, Z Killinger, P Jackuliak, P Vaňuga, D Hans, N Binkley, J Paye. Pathophysiology of growth hormone secretion disorders and their impact on bone microstructure as measured by trabecular bone score. Physiological research. vol 68. issue Suppl 2. 2020-05-01. PMID:31842575. |
this article is focused on endocrine-mediated osteoporosis caused by growth hormone (gh) disorders; adult gh deficiency and acromegaly. |
2020-05-01 |
2023-08-13 |
Not clear |
| Georgiana Dobri, Soamsiri Niwattisaiwong, James F Bena, Manjula Gupta, John Kirwan, Lawrence Kennedy, Amir H Hamrahia. Is GH nadir during OGTT a reliable test for diagnosis of acromegaly in patients with abnormal glucose metabolism? Endocrine. vol 64. issue 1. 2020-04-20. PMID:30415402. |
is gh nadir during ogtt a reliable test for diagnosis of acromegaly in patients with abnormal glucose metabolism? |
2020-04-20 |
2023-08-13 |
Not clear |
| Georgiana Dobri, Soamsiri Niwattisaiwong, James F Bena, Manjula Gupta, John Kirwan, Lawrence Kennedy, Amir H Hamrahia. Is GH nadir during OGTT a reliable test for diagnosis of acromegaly in patients with abnormal glucose metabolism? Endocrine. vol 64. issue 1. 2020-04-20. PMID:30415402. |
the growth hormone (gh) nadir during oral glucose tolerance test (ogtt) is the gold standard diagnostic test for acromegaly. |
2020-04-20 |
2023-08-13 |
Not clear |
| Georgiana Dobri, Soamsiri Niwattisaiwong, James F Bena, Manjula Gupta, John Kirwan, Lawrence Kennedy, Amir H Hamrahia. Is GH nadir during OGTT a reliable test for diagnosis of acromegaly in patients with abnormal glucose metabolism? Endocrine. vol 64. issue 1. 2020-04-20. PMID:30415402. |
in this study, we compared the gh nadir during ogtt in patients evaluated for acromegaly in the presence and absence of agm. |
2020-04-20 |
2023-08-13 |
Not clear |
| Federico Gatto, Claudia Campana, Francesco Cocchiara, Giuliana Corica, Manuela Albertelli, Mara Boschetti, Gianluigi Zona, Diego Criminelli, Massimo Giusti, Diego Feron. Current perspectives on the impact of clinical disease and biochemical control on comorbidities and quality of life in acromegaly. Reviews in endocrine & metabolic disorders. vol 20. issue 3. 2020-04-20. PMID:31342434. |
acromegaly is a rare chronic, systemic disorder caused by excessive growth hormone (gh) secretion from a somatotroph pituitary adenoma. |
2020-04-20 |
2023-08-13 |
Not clear |
| Federico Gatto, Claudia Campana, Francesco Cocchiara, Giuliana Corica, Manuela Albertelli, Mara Boschetti, Gianluigi Zona, Diego Criminelli, Massimo Giusti, Diego Feron. Current perspectives on the impact of clinical disease and biochemical control on comorbidities and quality of life in acromegaly. Reviews in endocrine & metabolic disorders. vol 20. issue 3. 2020-04-20. PMID:31342434. |
somatostatin receptor ligands, dopamine agonists and a gh receptor antagonist are currently available for medical therapy of acromegaly. |
2020-04-20 |
2023-08-13 |
Not clear |
| Min He, Niandong Zheng, Jing Zhang, Zhihong Hu, Guoliang You, Qingqing Ren, Hao Liu, Jianguo X. Growth hormone-secreting adenoma coexisted with gangliocytoma: a rare case. International journal of clinical and experimental pathology. vol 11. issue 7. 2020-03-25. PMID:31949764. |
we report a rare case of mixed gangliocytoma and growth hormone (gh)-secreting adenoma in a 50-year-old woman, who presented with acromegaly. |
2020-03-25 |
2023-08-13 |
Not clear |
| Kaori Hozumi, Hidenori Fukuoka, Yukiko Odake, Takehito Takeuchi, Tomoko Uehara, Takeshi Sato, Naoko Inoshita, Kenichi Yoshida, Ryusaku Matsumoto, Hironori Bando, Yushi Hirota, Genzo Iguchi, Masaaki Taniguchi, Naoki Otsuki, Chikako Nishigori, Kenjiro Kosaki, Tomonobu Hasegawa, Wataru Ogawa, Yutaka Takahash. Acromegaly caused by a somatotroph adenoma in patient with neurofibromatosis type 1. Endocrine journal. vol 66. issue 10. 2020-03-23. PMID:31189769. |
although acromegaly has been reported in patients with neurofibromatosis type 1 (nf1), these cases have not been associated with growth hormone (gh)-producing somatotroph adenoma, but with optic pathway glioma. |
2020-03-23 |
2023-08-13 |
Not clear |
| Kaori Hozumi, Hidenori Fukuoka, Yukiko Odake, Takehito Takeuchi, Tomoko Uehara, Takeshi Sato, Naoko Inoshita, Kenichi Yoshida, Ryusaku Matsumoto, Hironori Bando, Yushi Hirota, Genzo Iguchi, Masaaki Taniguchi, Naoki Otsuki, Chikako Nishigori, Kenjiro Kosaki, Tomonobu Hasegawa, Wataru Ogawa, Yutaka Takahash. Acromegaly caused by a somatotroph adenoma in patient with neurofibromatosis type 1. Endocrine journal. vol 66. issue 10. 2020-03-23. PMID:31189769. |
acromegaly was suspected due to her facial features, and subsequent examinations revealed the presence of gh excess with a pituitary tumor, leading to the diagnosis of acromegaly. |
2020-03-23 |
2023-08-13 |
Not clear |